Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.790
+0.125 (7.51%)
Sep 5, 2025, 4:00 PM - Market closed
Traws Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 13.08 | 21.34 | 20.82 | 38.76 | 55.07 | 19.03 | Upgrade |
Cash & Short-Term Investments | 13.08 | 21.34 | 20.82 | 38.76 | 55.07 | 19.03 | Upgrade |
Cash Growth | -22.53% | 2.48% | -46.28% | -29.62% | 189.46% | -16.29% | Upgrade |
Accounts Receivable | - | - | - | 0.03 | 0.03 | 0.04 | Upgrade |
Other Receivables | 1.32 | 1.77 | 0.02 | - | - | - | Upgrade |
Receivables | 1.32 | 1.77 | 0.02 | 0.03 | 0.03 | 0.04 | Upgrade |
Inventory | - | - | 0.19 | 0.1 | 0.03 | 0.09 | Upgrade |
Prepaid Expenses | 0.05 | 0.16 | 0.17 | 0.19 | 0.25 | 0.26 | Upgrade |
Other Current Assets | 0.92 | 1.69 | 1.46 | 0.27 | 0.05 | 0.37 | Upgrade |
Total Current Assets | 15.37 | 24.95 | 22.66 | 39.35 | 55.43 | 19.78 | Upgrade |
Property, Plant & Equipment | 0.01 | 0.01 | 0.02 | 0.02 | 0.04 | 0.05 | Upgrade |
Other Long-Term Assets | 0.24 | 0 | 0 | 0 | 0.01 | 0.15 | Upgrade |
Total Assets | 15.62 | 24.96 | 22.68 | 39.37 | 55.48 | 19.99 | Upgrade |
Accounts Payable | 4.76 | 8.19 | 5.62 | 3.86 | 2.76 | 4.83 | Upgrade |
Accrued Expenses | 2.59 | 3.12 | 3.38 | 3.96 | 3.13 | 4.96 | Upgrade |
Current Unearned Revenue | - | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | Upgrade |
Total Current Liabilities | 7.35 | 11.53 | 9.22 | 8.05 | 6.12 | 10.02 | Upgrade |
Long-Term Unearned Revenue | - | 2.57 | 2.79 | 3.02 | 3.24 | 3.47 | Upgrade |
Other Long-Term Liabilities | 0.01 | 42.49 | - | - | - | 0.32 | Upgrade |
Total Liabilities | 7.36 | 56.59 | 12.01 | 11.06 | 9.36 | 13.81 | Upgrade |
Common Stock | 0.07 | 0.04 | 0.01 | 0.21 | 0.21 | 0.12 | Upgrade |
Additional Paid-In Capital | 636.76 | 617.53 | 493.32 | 491.82 | 490.64 | 434.59 | Upgrade |
Retained Earnings | -628.58 | -649.15 | -482.63 | -463.68 | -444.72 | -428.56 | Upgrade |
Comprehensive Income & Other | 0.01 | -0.04 | -0.02 | -0.03 | -0.01 | 0.01 | Upgrade |
Total Common Equity | 8.26 | -31.63 | 10.67 | 28.31 | 46.12 | 6.18 | Upgrade |
Shareholders' Equity | 8.26 | -31.63 | 10.67 | 28.31 | 46.12 | 6.18 | Upgrade |
Total Liabilities & Equity | 15.62 | 24.96 | 22.68 | 39.37 | 55.48 | 19.99 | Upgrade |
Net Cash (Debt) | 13.08 | 21.34 | 20.82 | 38.76 | 55.07 | 19.03 | Upgrade |
Net Cash Growth | -22.53% | 2.48% | -46.28% | -29.62% | 189.46% | -16.29% | Upgrade |
Net Cash Per Share | 2.74 | 13.74 | 24.80 | 46.34 | 81.79 | 40.99 | Upgrade |
Filing Date Shares Outstanding | 7.06 | 5.07 | 0.84 | 0.84 | 0.84 | 0.63 | Upgrade |
Total Common Shares Outstanding | 7.07 | 3.65 | 0.84 | 0.84 | 0.84 | 0.5 | Upgrade |
Working Capital | 8.02 | 13.42 | 13.44 | 31.3 | 49.32 | 9.76 | Upgrade |
Book Value Per Share | 1.17 | -8.66 | 12.70 | 33.82 | 55.18 | 12.45 | Upgrade |
Tangible Book Value | 8.26 | -31.63 | 10.67 | 28.31 | 46.12 | 6.18 | Upgrade |
Tangible Book Value Per Share | 1.17 | -8.66 | 12.70 | 33.82 | 55.18 | 12.45 | Upgrade |
Machinery | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.